A Case Report of Hormone Receptor Positive and HER-2 Receptor Positive Metastatic Breast Cancer Stage IV Patient Treated with a Combination of Traditional Korean Medicine and Chemotherapy for 6 Years

박경주; 이아람; 김성수; 성신

doi:10.15432/JKTO.2019.24.2.013

권한신청
P-ISSN1010-0695
E-ISSN2288-3339

홈으로

전체 논문 목록

논문 상세

Home > 논문 상세

P-ISSN 1010-0695
E-ISSN 2288-3339

논문 투고

24권 2호

Citation Share

호르몬 수용체 및 HER-2 수용체 양성 유방암 4기 다발성 전이 환자의 6년간의 한양방 병용치료 치험 1례

A Case Report of Hormone Receptor Positive and HER-2 Receptor Positive Metastatic Breast Cancer Stage IV Patient Treated with a Combination of Traditional Korean Medicine and Chemotherapy for 6 Years

대한한의학회지 / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339

2003, v.24 no.2, pp.13-21

https://doi.org/10.15432/JKTO.2019.24.2.013

박경주 (소람한방병원)
이아람 (소람한방병원)
김성수 (소람한방병원)
성신 (소람한방병원)

박경주, 이아람, 김성수, & 성신. (2003). 호르몬 수용체 및 HER-2 수용체 양성 유방암 4기 다발성 전이 환자의 6년간의 한양방 병용치료 치험 1례. 대한한의학회지, 24(2), 13-21, https://doi.org/10.15432/JKTO.2019.24.2.013

복사

다운로드 수
조회수

PDF 다운로드

Abstract

Objective : The purpose of this study is to report and observe effects of Traditional Korean Medicine (TKM) on stage IV metastatic breast cancer patient. Method : A right breast cancer patient diagnosed with metastatic lesions on liver, lung, spleen, multiple bones and skin on right breast April 2013. The patient received Herceptin + Docetaxel + Zometa from May 2013 and started to receive TKM since July 2013 to decrease side effects of chemotherapy. From December 2013 to November 2014, she had received Herceptin 18 times more. The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA15-3), liver function test (AST, ALT), and numeric rating scales (NRS). Results : After 6 years of TKM treatment combined with standard chemotherapy, tumor size was partially decreased in lung, liver, right pleura and spleen. Levels of tumor markers also showed decrease. There were no severe adverse events induced by TKM based on National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE) version 4.0. Conclusion : This case suggests that TKM combined with standard chemotherapy could be a promising method for treating metastatic stage IV breast cancer.

keywords: Breast cancer, Herbal medicine, Integrative Cancer Treatment, Traditional Korean Medicine

다운로드 수
조회수

0KCI 피인용수
0WOS 피인용수

논문 상세

호르몬 수용체 및 HER-2 수용체 양성 유방암 4기 다발성 전이 환자의 6년간의 한양방 병용치료 치험 1례

A Case Report of Hormone Receptor Positive and HER-2 Receptor Positive Metastatic Breast Cancer Stage IV Patient Treated with a Combination of Traditional Korean Medicine and Chemotherapy for 6 Years

Abstract

권호 내 다른 논문

추천 논문

권호 목록

소개

규정 및 지침

게시판

대한한의학회지